% Expired Patents = 88.9

EPO Patents = 2

Forward Citations = 56

Loading Chart...

3 inventors (with patents filed for the assignee):

Radhakrishnan P Iyer (9 out of 38 patents)

Seetharamaiyer Padmanabhan (8 out of 16 patents)

John E Coughlin (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 10376533 - Compositions and methods for treating viral infections (2019-08-13),

2. 10344046 - Nucleotide and oligonucleotide prodrugs (2019-07-09),

3. 10047114 - Nucleotide and oligonucleotide prodrugs (2018-08-14),

4. 9539276 - Compositions and methods for treating viral infections (2017-01-10),

5. 9138442 - Compositions and methods for treating viral infections (2015-09-22),

6. 9040234 - Oligonucleotide analogs as therapeutic agents (2015-05-26),

7. 8691787 - Nucleotide and oligonucleotide prodrugs (2014-04-08),

8. 8404651 - Compositions and methods for treating viral infections (2013-03-26),

9. 8076303 - Nucleotide and oligonucleotide prodrugs (2011-12-13),

Company Overview

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases. The company's lead product candidate, inarigivir, is being developed for the treatment of chronic hepatitis B virus (HBV) infection. Spring Bank is committed to delivering innovative solutions to improve patients' lives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#11 in Hopkinton, MA

#1,926 in Massachusetts

#32,588 in US

Hopkinton, MA, United States of America

Spring Bank Pharmaceuticals, Inc.

Forward Citations = 56

3 inventors:

Radhakrishnan P Iyer (9 out of 38 patents)

Seetharamaiyer Padmanabhan (8 out of 16 patents)

John E Coughlin (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Spring Bank Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/spring-bank-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]